Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0033 | 0.4266 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.0734 | 0.0643 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0033 | 0.3118 |
Loa Loa (eye worm) | inositol-1 | 0.0037 | 0.0097 | 0.0093 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0033 | 0.4266 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0629 | 0.297 | 1 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0033 | 0.0078 | 1 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0033 | 0.0078 | 1 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0037 | 0.0097 | 0.5 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0005 | 0.5 |
Echinococcus granulosus | geminin | 0.0168 | 0.0734 | 0.0643 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0033 | 0.3118 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0037 | 0.0097 | 1 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0037 | 0.0097 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0033 | 0.3118 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0033 | 0.3118 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0033 | 0.0029 |
Schistosoma mansoni | protein kinase | 0.2077 | 1 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0033 | 0.3118 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0033 | 0.0029 |
Brugia malayi | Inositol-1 | 0.0037 | 0.0097 | 0.0064 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0033 | 0.3118 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.2077 | 1 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0033 | 0.3118 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0005 | 0.5 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0037 | 0.0097 | 0.5 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0005 | 0.5 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0037 | 0.0097 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2074 | 0.9985 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0033 | 0.0029 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.0734 | 0.0643 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0037 | 0.0097 | 0.5 |
Onchocerca volvulus | 0.0023 | 0.0033 | 0.5 | |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0037 | 0.0097 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0625 | 0.2955 | 0.2956 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0037 | 0.0097 | 0.5 |
Echinococcus multilocularis | geminin | 0.0168 | 0.0734 | 0.0643 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0037 | 0.0097 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0005 | 0.0593 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0033 | 0.3118 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.2077 | 1 | 1 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0629 | 0.297 | 1 |
Schistosoma mansoni | protein kinase | 0.2077 | 1 | 1 |
Loa Loa (eye worm) | STE/STE11/ASK protein kinase | 0.0629 | 0.297 | 0.2971 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.234 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.817 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.815 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.811 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.773 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.757 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.736 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.731 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.71 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.417 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.